human genome

The Food and Drug Administration on Wednesday approved the first new drug to treat lupus in 56 years. It's not terribly effective: It only worked for 35% of the patients tested. But experts say the approval could prompt the development of more effective drugs.

Swiss pharmaceutical company Novartis announced Tuesday that it had discontinued the development of two drugs -- the hepatitis C treatment Zalbin, and antifungal agent Mycograb. The company will take impairment charges of approximately $590 million in third quarter of 2010.

Nearly 20 years ago the Apple Newton became the first device to be called a PDA, 14 years ago Nokia provided a newly mobile world with the 9000 Communicator, which was the first phone with PDA functions. Since then we have quickly become a nation that relies on our phones to help us remember...

Human Genome Sciences (HGSI) and GlaxoSmithKline (GSK) say their experimental lupus drug passed another key treatment goal and they plan on asking for regulatory approval in the first half of 2010. Wall Street and researchers anticipated study data from Bliss-76, hoping it would confirm positive...